Two Sigma Investments, LP Vanda Pharmaceuticals Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 532,280 shares of VNDA stock, worth $2.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

532,280

Previous 783,004 32.02%

Holding current value

$2.72 Million

Previous $3.3 Million 33.81%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $870,012 - $1.16 Million	-250,724 Reduced 32.02%	532,280 $2.19 Million
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $606,547 - $821,890	179,452 Added 29.73%	783,004 $3.3 Million
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $280,476 - $430,545	-65,532 Reduced 9.79%	603,552 $2.61 Million
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $948,885 - $1.12 Million	160,828 Added 31.64%	669,084 $4.41 Million
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $382,449 - $494,461	61,885 Added 13.86%	508,256 $3.45 Million

Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $617,248 - $984,723	89,847 Added 25.2%	446,371 $3.3 Million
Q3 2022 Nov 14, 2022	SELL	$9.44 - $11.76 $498,847 - $621,445	-52,844 Reduced 12.91%	356,524 $3.52 Million
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $989,047 - $1.26 Million	106,235 Added 35.05%	409,368 $4.46 Million
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $304,885 - $465,485	-28,126 Reduced 8.49%	303,133 $3.43 Million
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $3.28 Million - $4.42 Million	209,014 Added 170.98%	331,259 $5.2 Million
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $1.87 Million - $2.59 Million	-121,596 Reduced 49.87%	122,245 $2.1 Million
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $993,720 - $1.36 Million	63,254 Added 35.03%	243,841 $5.25 Million
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $1.78 Million - $2.68 Million	132,330 Added 274.22%	180,587 $2.71 Million
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $471,470 - $666,429	48,257 New	48,257 $634,000
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $978,627 - $1.26 Million	-105,003 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $602,861 - $750,144	-62,408 Reduced 37.28%	105,003 $1.2 Million
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $1.69 Million - $3.79 Million	-225,307 Reduced 57.37%	167,411 $1.73 Million
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $2.01 Million - $2.83 Million	162,179 Added 70.35%	392,718 $6.45 Million
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $2.59 Million - $3.34 Million	-211,463 Reduced 47.84%	230,539 $3.06 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $521,938 - $735,866	39,038 Added 9.69%	442,002 $6.23 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $1.38 Million - $2.44 Million	78,655 Added 24.25%	402,964 $7.42 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $683,868 - $1.13 Million	-36,050 Reduced 10.0%	324,309 $8.47 Million
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $102,346 - $128,984	5,608 Added 1.58%	360,359 $8.27 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $19.15 $2.52 Million - $3.45 Million	180,314 Added 103.37%	354,751 $6.76 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $2.19 Million - $3.15 Million	156,037 Added 848.03%	174,437 $2.94 Million
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $2.38 Million - $3.36 Million	-185,558 Reduced 90.98%	18,400 $280,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $3.14 Million - $3.84 Million	203,958	203,958 $3.65 Million

Others Institutions Holding VNDA

# of Institutions

147

Shares Held

49.6M

Call Options Held

49.1K

Put Options Held

107K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $289M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Vanda Pharmaceuticals Inc. Transaction History